Neonatal Abstinence Syndrome. Neonatal withdrawal symptoms from maternal use of drugs of addiction
Conditions
Interventions
Intervention 1: Intervention group 1 (morphine): In this group, there are 50 patients who are receiving morphine drug treatment. The decision to start drug treatment will be based on the Fingan scorin
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Days to 28 Days
Inclusion criteria
Inclusion criteria: Infants of mothers who have taken morphine derivatives due to abuse or relief of chronic pain and have been visited at least once or twice for pregnancy care in the third trimester and are able to survive.
Exclusion criteria
Exclusion criteria: Mothers who consume alcohol Congenital and genetic abnormalities. Taking benzodiazepines during pregnancy Infants who are unable to survive or whose survival is in doubt.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of hospitalization. Timepoint: Duration of hospitalization. Method of measurement: Therapist's observations.;Duration of treatment. Timepoint: Duration of hospitalization. Method of measurement: Therapist's observations.;Side effects of drugs. Timepoint: Duration of hospitalization. Method of measurement: Therapist's observations. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBahareh Bahman Bijari
Kerman University of Medical Sciences
Outcome results
None listed